Hrs-4642

KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting

Jiangsu HengRui Medicine Co., Ltd.Phase 3

—

Rating in progress

Hrs-4642 in KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active